The invention is in the field of medical treatments. The invention in particular addresses the treatment of lysozomal lipid storage diseases such as Niemann-Pick disease type C1. More in particular, the invention relates to a method for treating, ameliorating of preventing inflammation in a lysozomal storage disease, wherein the level of anti-oxLDL antibodies is increased in a subject in need of such a treatment.
